1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2016-2027)
2.2 Tuberculosis (TB) Diagnostics Growth Trends by Regions
2.2.1 Tuberculosis (TB) Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tuberculosis (TB) Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Tuberculosis (TB) Diagnostics Industry Dynamic
2.3.1 Tuberculosis (TB) Diagnostics Market Trends
2.3.2 Tuberculosis (TB) Diagnostics Market Drivers
2.3.3 Tuberculosis (TB) Diagnostics Market Challenges
2.3.4 Tuberculosis (TB) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue
3.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis (TB) Diagnostics Revenue
3.4 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2020
3.5 Tuberculosis (TB) Diagnostics Key Players Head office and Area Served
3.6 Key Players Tuberculosis (TB) Diagnostics Product Solution and Service
3.7 Date of Enter into Tuberculosis (TB) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis (TB) Diagnostics Breakdown Data by Type
4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2022-2027)
5 Tuberculosis (TB) Diagnostics Breakdown Data by Application
5.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Market Size (2016-2027)
6.2 North America Tuberculosis (TB) Diagnostics Market Size by Type
6.2.1 North America Tuberculosis (TB) Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Tuberculosis (TB) Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Tuberculosis (TB) Diagnostics Market Size by Type (2016-2027)
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Application
6.3.1 North America Tuberculosis (TB) Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Tuberculosis (TB) Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Tuberculosis (TB) Diagnostics Market Size by Application (2016-2027)
6.4 North America Tuberculosis (TB) Diagnostics Market Size by Country
6.4.1 North America Tuberculosis (TB) Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Tuberculosis (TB) Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Diagnostics Market Size (2016-2027)
7.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type
7.2.1 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2016-2027)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Application
7.3.1 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2016-2027)
7.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country
7.4.1 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Type
8.2.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Application
8.3.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region
8.4.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tuberculosis (TB) Diagnostics Market Size (2016-2027)
9.2 Latin America Tuberculosis (TB) Diagnostics Market Size by Type
9.2.1 Latin America Tuberculosis (TB) Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Tuberculosis (TB) Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Application
9.3.1 Latin America Tuberculosis (TB) Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Tuberculosis (TB) Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Country
9.4.1 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type
10.2.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application
10.3.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
10.4.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction
11.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.1.5 Danaher Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Tuberculosis (TB) Diagnostics Introduction
11.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Tuberculosis (TB) Diagnostics Introduction
11.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.4.5 BD Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction
11.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction
11.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.6.5 Hologic Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction
11.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.7.5 Qiagen Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Details
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction
11.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.8.5 BioMerieux Recent Development
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Details
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction
11.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.9.5 Hain Lifescience Recent Development
11.10 Oxford Immunotec
11.10.1 Oxford Immunotec Company Details
11.10.2 Oxford Immunotec Business Overview
11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction
11.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2016-2021)
11.10.5 Oxford Immunotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
